MRI Stem Cell Tracking for Therapy in Experimental Cerebral Ischemia

Translational Stroke Research

Volumn 3, Issue 1, 2012, Pages 22-35

  Ramos Cabrer, Pedro ^a   Hoehn, Mathias ^b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

Cell labeling strategies; Functional improvement; Functional MRI; Monitoring of stem cell dynamics; Neurogenesis; Stem cell engraftment

Indexed keywords

GADOLINIUM CHELATE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUPERPARAMAGNETIC IRON OXIDE;

AUTOLOGOUS STEM CELL TRANSPLANTATION; BIOLUMINESCENCE; BRAIN ISCHEMIA; CELL FATE; CELL LABELING; CELL TRACKING; CONTRAST ENHANCEMENT; ENGRAFTMENT; FLUORINE NUCLEAR MAGNETIC RESONANCE; HUMAN; IMAGE ANALYSIS; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; STEM CELL TRANSPLANTATION; THERAPY EFFECT;

EID: 84857646022     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-011-0111-3     Document Type: Review

References (123)

1. 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci. 2002; 99(5): 3030-5. doi: 10. 1073/pnas. 052709599.
2. Ahrens ET, Flores R, Xu H, Morel PA. In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol. 2005; 23: 983-7.
3. Aime S, Castelli DD, Crich SG, Gianolio E, Terreno E. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. Acc Chem Res. 2009; 42(7): 822-31. doi: 10. 1021/ar800192p.
4. Ali MM, Yoo B, Pagel MD. Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI. Mol Pharm. 2009; 6(5): 1409-16. doi: 10. 1021/mp900040u.
5. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med. 2002; 8: 963-70.
6. Aswendt M, Gianolio E, Pariani G, Napolitano R, Fedeli F, Himmelreich U et al. Imaging GABAergic neurons by MRI: use of a responsive contrast agent for gluatmic acid decarboxylase. Proceedings of the European Molecular Imaging Meeting in Leiden, NL. 2011; 30.
7. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005; 57(6): 874-82. doi: 10. 1002/ana. 20501.
8. Bendszus M, Stoll G. Caught in the act: in vivo mapping of macrophage infiltration in nerve injury by magnetic resonance imaging. J Neurosci. 2003; 23(34): 10892-6.
9. Böhm-Sturm P, Mengler LM, Wecker SW, Hoehn M. In vivo tracking of human neural stem cells in the mouse brain with 19F MRI Proceedings of the European Molecular Imaging Meeting in Leiden, NL. 2011: 49.
10. Boncoraglio Giorgio B, Bersano A, Candelise L, Reynolds Brent A, Parati Eugenio A. Stem cell transplantation for ischemic stroke. Cochrane Database Syst Rev. 2010. doi: 10. 1002/14651858. CD007231. pub2.
11. Brea D, Sobrino T, Ramos-Cabrer P, Castillo J. Inflammatory and neuroimmunomodulatory changes in acute cerebral ischemia. Cerebrovasc Dis. 2009; 27 suppl 1: 48-64.
12. Bulte JWM, Douglas T, Witwer B, Zhang S-C, Strable E, Lewis BK, et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol. 2001; 19: 1141-7.
13. Bulte JWM, Zhang S-C, van Gelderen P, Herynek V, Jordan EK, Duncan ID, et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A. 1999; 96(26): 15256-61. doi: 10. 1073/pnas. 96. 26. 15256.
14. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001; 32(11): 2682-8. doi: 10. 1161/hs1101. 098367.
15. Chung D-J, Choi C-B, Lee S-H, Kang E-H, Lee J-H, Hwang S-H, et al. Intraarterially delivered human umbilical cord blood-derived mesenchymal stem cells in canine cerebral ischemia. J Neurosci Res. 2009; 87(16): 3554-67. doi: 10. 1002/jnr. 22162.
16. Cohen B, Ziv K, Plaks V, Israely T, Kalchenko V, Harmelin A et al. MRI detection of transcriptional regulation of gene expression in transgenic mice. Nat Med. 2007; 13(4): 498-503. http://www. nature. com/nm/journal/v13/n4/suppinfo/nm1497_S1. html.
17. Cormode DP, Jarzyna PA, Mulder WJM, Fayad ZA. Modified natural nanoparticles as contrast agents for medical imaging. Adv Drug Deliv Rev. 2010; 62(3): 329-38.
18. Couillard-Despres S, Finkl R, Winner B, Ploetz S, Wiedermann D, Aigner R, et al. In vivo optical imaging of neurogenesis: watching new neurons in the intact brain. Mol Imaging. 2008; 7(1): 28-34.
19. Couillard-Despres S, Vreys R, Aigner L, van Der Linden A. In vivo monitoring of adult neurogenesis in health and disease. Front Neurosci. 2011; 5. doi: 10. 3389/fnins. 2011. 00067.
20. Daadi MM, Maag A-L, Steinberg GK. Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model. PLoS One. 2008; 3(2): e1644.
21. Darsalia V, Allison SJ, Cusulin C, Monni E, Kuzdas D, Kallur T, et al. Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain. J Cereb Blood Flow Metab. 2011; 31: 235-42.
22. Darsalia V, Kallur T, Kokaia Z. Survival, migration and neuronal differentiation of human fetal striatal and cortical neural stem cells grafted in stroke-damaged rat striatum. Eur J Neurosci. 2007; 26(3): 605-14. doi: 10. 1111/j. 1460-9568. 2007. 05702. x.
23. Dodd SJ, Williams M, Suhan JP, Williams DS, Koretsky AP, Ho C. Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J. 1999; 76(1): 103-9.
24. Duimstra JA, Femia FJ, Meade TJ. A gadolinium chelate for detection of β-glucuronidase: a self-immolative approach. J Am Chem Soc. 2005; 127(37): 12847-55. doi: 10. 1021/ja042162r.
25. Einstein O, Ben-Hur T. The changing face of neural stem cell therapy in neurologic diseases. Arch Neurol. 2008; 65(4): 452-6. doi: 10. 1001/archneur. 65. 4. 452.
26. Elhami E, Goertzen A, Xiang B, Deng J, Stillwell C, Mzengeza S, et al. Viability and proliferation potential of adipose-derived stem cells following labeling with a positron-emitting radiotracer. Eur J Nucl Med Mol Imaging. 2011; 38(7): 1323-34. doi: 10. 1007/s00259-011-1753-9.
27. England T, Martin P, Bath PMW. Stem cells for enhancing recovery after stroke: a review. Int J Stroke. 2009; 4(2): 101-10. doi: 10. 1111/j. 1747-4949. 2009. 00253. x.
28. Farr TD, Kallur T, Wiedermann D, Couillard-Després S, Aigner L, Hoehn M. Live imaging of stroke induced neurogenesis in the mouse brain. Proceedings of the Annual Scientific Meeting of the ISMRM, Honolulu, Hawaii. 2009.
29. Farr TD, Seehafer JU, Nelles M, Hoehn M. Challenges towards MR imaging of the peripheral inflammatory response in the subacute and chronic stages of transient focal ischemia. NMR Biomed. 2011; 24(1): 35-45. doi: 10. 1002/nbm. 1553.
30. Gilad AA, Ziv K, McMahon MT, van Zijl PCM, Neeman M, Bulte JWM. MRI reporter genes. J Nucl Med. 2008; 49(12): 1905-8. doi: 10. 2967/jnumed. 108. 053520.
31. Granot D, Scheinost D, Markakis EA, Papademetris X, Shapiro EM. Serial monitoring of endogenous neuroblast migration by cellular MRI. NeuroImage. 2011; 57(3): 817-24.
32. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005; 26(18): 3995-4021.
33. Gupta AK, Naregalkar RR, Vaidya VD, Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine. 2007; 2(1): 23-39. doi: 10. 2217/17435889. 2. 1. 23.
34. Guzman R, Uchida N, Bliss TM, He D, Christopherson KK, Stellwagen D, et al. Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A. 2007; 104(24): 10211-6. doi: 10. 1073/pnas. 0608519104.
35. Hancu I, Dixon WT, Woods M, Vinogradov E, Sherry AD, Lenkinski RE. CEST and PARACEST MR contrast agents. Acta Radiol. 2010; 51(8): 910-23. doi: 10. 3109/02841851. 2010. 502126.
36. Harney AS, Meade TJ. Molecular imaging of in vivo gene expression. Future Med Chem. 2010; 2(3): 503-19. doi: 10. 4155/fmc. 09. 168.
37. Hawrylak N, Ghosh P, Broadus J, Schlueter C, Greenough WT, Lauterbur PC. Nuclear magnetic resonance (NMR) imaging of iron oxide-labeled neural transplants. Exp Neurol. 1993; 121(2): 181-92. doi: 10. 1006/exnr. 1993. 1085.
38. Helfer BM, Balducci A, Nelson AD, Janjic JM, Gil RR, Kalinski P, et al. Functional assesment of human dendritic cells labeled for in vivo F-19 magnetic resonance cell tracking. Cytotherapy. 2010; 12: 238-50.
39. Helm L. Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications. Future Med Chem. 2010; 2(3): 385-96.
40. Himmelreich U, Aime S, Hieronymus T, Justicia C, Uggeri F, Zenke M, et al. A responsive MRI contrast agent to monitor functional cell status. NeuroImage. 2006; 32(3): 1142-9.
41. Himmelreich U, Dresselaers T. Cell labeling and tracking for experimental models using magnetic resonance imaging. Methods. 2009; 48(2): 112-24.
42. Himmelreich U, Hoehn M. Stem cell labeling for magnetic resonance imaging. Minim Invasive Ther Allied Technol. 2008; 17(2): 132-42. doi: 10. 1080/13645700801969873.
43. Himmelreich U, Weber R, Ramos-Cabrer P, Wegener S, Kandal K, Shapiro EM, et al. Improved stem cell MR detectability in animal models by modification of the inhalation gas. Mol Imaging. 2005; 4(2): 104-9.
44. Hoehn M, Himmelreich U. In vivo molecular MR imaging-potential and limits. In: Webb GA, editor. Annual reports in NMR spectroscopy-handbook of modern magnetic resonance, section medical science. London: Kluwer Academic Publishers; 2006. p. 133-48.
45. Hoehn M, Küstermann E, Blunk J, Wiedermann D, Trapp T, Wecker S, et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A. 2002; 99(25): 16267-72. doi: 10. 1073/pnas. 242435499.
46. Hoehn M, Küstermann E, Wiedermann D, Bührle C, Blunk J, Weber R, et al., editors. Stem cell migration after stroke observed by in vivo MR imaging. Pharmacology of cerebral ischemia. Stuttgart: Medpharm Scientific Publishers; 2004.
47. Hoehn M, Wiedermann D, Justicia C, Ramos-Cabrer P, Kruttwig K, Farr T, et al. Cell tracking using magnetic resonance imaging. J Physiol. 2007; 584(1): 25-30. doi: 10. 1113/jphysiol. 2007. 139451.
48. Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S, Onodera R, et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain. 2011; 134(6): 1790-807. doi: 10. 1093/brain/awr063.
49. 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for microPET imaging. Mol Imaging. 2008; 7(1): 1-11.
50. Jander S, Schroeter M, Saleh A. Imaging Inflammation in acute brain ischemia. Stroke. 2007; 38(2): 642-5. doi: 10. 1161/01. STR. 0000250048. 42916. ad.
51. Jendelová P, Herynek V, DeCroos J, Glogarová K, Andersson B, Hájek M, et al. Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magn Reson Med. 2003; 50(4): 767-76. doi: 10. 1002/mrm. 10585.
52. Jiang Q, Zhang ZG, Ding GL, Zhang L, Ewing JR, Wang L, et al. Investigation of neural progenitor cell induced angiogenesis after embolic stroke in rat using MRI. NeuroImage. 2005; 28(3): 698-707. doi: 10. 1016/j. neuroimage. 2005. 06. 063.
53. Justicia C, Himmelreich U, Ramos-Cabrer P, Sprenger C, Hoehn M. In vivo tracking of endogenous stem cells by MRI after intraparenchymal injection of iron oxide nanoparticles. Mol Imaging. 2005; 4: 351-2.
54. Kallur T, Farr TD, Böhm-Sturm P, Kokaia Z, Hoehn M. Spatio-temporal dynamics, differentiation and viability of human neural stem cells after implantation into neonatal rat brain. Eur J Neurosci. 2011. doi: 10. 1111/j. 1460-9568. 2011. 07759. x.
55. Karussis D, Kassis I, Kurkalli BGS, Slavin S. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases. J Neurol Sci. 2008; 265(1): 131-5.
56. Kim D-E, Schellingerhout D, Ishii K, Shah K, Weissleder R. Imaging of stem cell recruitment to ischemic infarcts in a murine model. Stroke. 2004; 35(4): 952-7. doi: 10. 1161/01. str. 0000120308. 21946. 5d.
57. Kim D, Chun B-G, Kim Y-K, Lee YH, Park C-S, Jeon I, et al. In vivo tracking of human mesenchymal stem cells in experimental stroke. Cell Transplant. 2007; 16: 1007-12.
58. Koehne G, Doubrovin M, Doubrovina E, Zanzonico P, Gallardo HF, Ivanova A, et al. Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat Biotech. 2003; 21(4): 405-13.
59. Kondziolka D, Wechsler L, Goldstein S, Meltzer C, Thulborn KR, Gebel J, et al. Transplantation of cultured human neuronal cells for patients with stroke. Neurology. 2000; 55(4): 565-9.
60. Kraitchman D, Bulte J. Imaging of stem cells using MRI. Basic Res Cardiol. 2008; 103(2): 105-13. doi: 10. 1007/s00395-008-0704-5.
61. Kruttwig K, Brueggemann C, Kaijzel E, Vorhagen S, Hilger T, Löwik C, et al. Development of a three-dimensional in vitro model for longitudinal observation of cell behavior: monitoring by magnetic resonance imaging and optical imaging. Mol Imaging Biol. 2010; 12(4): 367-76. doi: 10. 1007/s11307-009-0289-x.
62. Küstermann E, Himmelreich U, Kandal K, Geelen T, Ketkar A, Wiedermann D, et al. Efficient stem cell labeling for MRI studies. Contrast Media Mol Imaging. 2008; 3(1): 27-37. doi: 10. 1002/cmmi. 229.
63. Laurent S, Bridot J-L, Elst LV, Muller RN. Magnetic iron oxide nanoparticles for biomedical applications. Future Med Chem. 2010; 2(3): 427-49. doi: 10. 4155/fmc. 09. 164.
64. Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells. 2010; 28(6): 1099-106. doi: 10. 1002/stem. 430.
65. Li X, Blizzard KK, Zeng Z, DeVries AC, Hurn PD, McCullough LD. Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender. Exp Neurol. 2004; 187(1): 94-104. doi: 10. 1016/j. expneurol. 2004. 01. 004.
66. Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX, et al. Human marrow stromal cell therapy for stroke in rat. Neurology. 2002; 59(4): 514-23.
67. Lindvall O, Kokaia Z. Stem Cell Research in Stroke. Stroke. 2011. (in press). doi. 10. 1161/strokeaha. 110. 599654. doi: 10. 1161/strokeaha. 110. 599654.
68. Liu W, Frank JA. Detection and quantification of magnetically labeled cells by cellular MRI. Eur J Radiol. 2009; 70(2): 258-64.
69. Liu Y, Lang B, Baskaya M, Dempsey R, Vemuganti R. The potential of neural stem cells to repair stroke-induced brain damage. Acta Neuropathol. 2009; 117(5): 469-80. doi: 10. 1007/s00401-009-0516-1.
70. Lois C, Alvarez-Buylla A. Long-distance neuronal migration in the adult mammalian brain. Science. 1994; 264: 1145-8.
71. Lundberg C, Martínez-Serrano A, Cattaneo E, McKay RDG, Björklund A. Survival, integration, and differentiation of neural stem cell lines after transplantation to the adult rat striatum. Exp Neurol. 1997; 145(2): 342-60.
72. Lundberg J, Södersten E, Sundström E, Blanc KL, Andersson T, Hermanson O, et al. Targeted intra-arterial transplantation of stem cells to the injured CNS is more effective than intravenous administration-engraftment is dependent on cell type and adhesion molecule expression. Cell Transplant. 2011. doi: 10. 3727/096368911X576036.
73. Matson ML, Wilson LJ. Nanotechnology and MRI contrast enhancement. Future Med Chem. 2010; 2(3): 491-502. doi: 10. 4155/fmc. 10. 3.
74. Modo M, Beech JS, Meade TJ, Williams SCR, Price J. A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke. Neuroimage. 2009; 47 Suppl 2: T133-42. doi: 10. 1016/j. neuroimage. 2008. 06. 017.
75. Modo M, Cash D, Mellodew K, Williams SCR, Fraser SE, Meade TJ, et al. Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage. 2002; 17(2): 803-11. doi: 10. 1006/nimg. 2002. 1194.
76. Modo M, Hoehn M, Bulte JW. Cellular MR imaging. Mol Imaging. 2005; 4(3): 143-64.
77. Modo M, Stroemer RP, Tang E, Patel S, Hodges H. Effects of implantation site of stem cell grafts on behavioral recovery from stroke damage. Stroke. 2002; 33(9): 2270-8. doi: 10. 1161/01. str. 0000027693. 50675. c5.
78. Mulder WJM, Strijkers GJ, Griffioen AW, van Bloois L, Molema G, Storm G, et al. A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. Bioconjugate Chem. 2004; 15(4): 799-806. doi: 10. 1021/bc049949r.
79. Mulder WJM, Strijkers GJ, van Tilborg GAF, Griffioen AW, Nicolay K. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed. 2006; 19(1): 142-64. doi: 10. 1002/nbm. 1011.
80. Obenaus A, Dilmac N, Tone B, Tian HR, Hartman R, Digicaylioglu M, et al. Long-term magnetic resonance imaging of stem cells in neonatal ischemic injury. Ann Neurol. 2011; 69(2): 282-91. doi: 10. 1002/ana. 22168.
81. Partlow KC, Chen JJ, Brant JA, Neubauer AM, Meyerrose TE, Creer MH, et al. F-19 magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J. 2007; 21(8): 1647-54. doi: 10. 1096/fj. 06-6505com.
82. Pluchino S, Zanotti L, Rossi B, Brambilla E, Ottoboni L, Salani G et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature. 2005; 436(7048): 266-71. doi: http://www. nature. com/nature/journal/v436/n7048/suppinfo/nature03889_S1. html.
83. Ramos-Cabrer P, Justicia C, Wiedermann D, Hoehn M. Stem cell mediation of functional recovery after stroke in the rat. PLoS One. 2010; 5(9): e12779.
84. Reumers V, Deroose CM, Krylychkina O, Nuyts J, Geraerts M, Mortelmans L, et al. Noninvsive and quantitative monitoring of adult neuronal stem cell migration in mouse brain using bioluminescence imaging. Stem Cells. 2008; 26: 2382-90.
85. Rueger MA, Backes H, Walberer M, Neumaier B, Ullrich R, Simard M-L, et al. Noninvasive imaging of endogenous neural stem cell mobilization in vivo using positron emission tomography. J Neurosci. 2010; 30(18): 6454-60. doi: 10. 1523/jneurosci. 6092-09. 2010.
86. Saleh A, Wiedermann D, Schroeter M, Jonkmanns C, Jander S, Hoehn M. Central nervous system inflammatory response after cerebral infarction as detected by magnetic resonance imaging. NMR Biomed. 2004; 17: 163-9.
87. Schwarz S, Fernandes F, Sanroman L, Hodenius M, Lang C, Himmelreich U, et al. Synthetic and biogenic magnetic nanoparticles for tracking of stem cells and dendritic cells. MAGMA. 2009; 321: 1533-8.
88. Shapiro EM, Gonzalez-Perez O, Manuel García-Verdugo J, Alvarez-Buylla A, Koretsky AP. Magnetic resonance imaging of the migration of neuronal precursors generated in the adult rodent brain. Neuroimage. 2006; 32(3): 1150-7.
89. Shapiro EM, Sharer K, Skrtic S, Koretsky AP. In vivo detection of single cells by MRI. Magn Reson Med. 2006; 55(2): 242-9. doi: 10. 1002/mrm. 20718.
90. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP. MRI detection of single particles for cellular imaging. Proc Natl Acad Sci U S A. 2004; 101(30): 10901-6. doi: 10. 1073/pnas. 0403918101.
91. Shen LH, Li Y, Chen J, Zhang J, Vanguri P, Borneman J, et al. Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience. 2006; 137(2): 393-9. doi: 10. 1016/j. neuroscience. 2005. 08. 092.
92. Shimada IS, Spees JL. Stem and progenitor cells for neurological repair: minor issues, major hurdles, and exciting opportunities for paracrine-based therapeutics. J Cell Biochem. 2011; 112(2): 374-80. doi: 10. 1002/jcb. 22963.
93. So M-K, Xu C, Loening AM, Gambhir SS, Rao J. Self-illuminating quantum dot conjugates for in vivo imaging. Nat Biotech. 2006; 24(3): 339-43. doi: http://www. nature. com/nbt/journal/v24/n3/suppinfo/nbt1188_S1. html.
94. Srinivas M, Morel PA, Ernst LA, Laidlaw DH, Ahrens ET. Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn Reson Med. 2007; 58(4): 725-34. doi: 10. 1002/mrm. 21352.
95. Srinivas M, Turner MS, Janjic JM, Morel PA, Laidlaw DH, Ahrens ET. In vivo cytometry of antigen-specific T cells using F-19 MRI. Magn Reson Med. 2009; 62(3): 747-53. doi: 10. 1002/mrm. 22063.
96. Stoll G, Bendszus M. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging. Neuroscience. 2009; 158(3): 1151-60.
97. Strijkers GJ, Mulder WJM, van Heeswijk RB, Frederik PM, Bomans P, Magusin PCMM, et al. Relaxivity of liposomal paramagnetic MRI contrast agents. Magn Reson Mater Phys Biol Med. 2005; 18(4): 186-92. doi: 10. 1007/s10334-005-0111-y.
98. Strijkers GJ, Mulder WJM, van Tilborg GAF, Nicolay K. MRI contrast agents: current status and future perspectives. Anticancer Agents Med Chem. 2007; 7(3): 291-305.
99. Stroemer P, Patel S, Hope A, Oliveira C, Pollock K, Sinden J. The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion. Neurorehabil Neural Repair. 2009; 23(9): 895-909. doi: 10. 1177/1545968309335978.
100. Sumner JP, Shapiro EM, Maric D, Conroy R, Koretsky AP. In vivo labeling of adult neural progenitors for MRI with micron sized particles of iron oxide: quantification of labeled cell phenotype. Neuroimage. 2009; 44(3): 671-8.
101. Sutton E, Henning T, Pichler B, Bremer C, Daldrup-Link H. Cell tracking with optical imaging. Eur Radiol. 2008; 18(10): 2021-32. doi: 10. 1007/s00330-008-0984-z.
102. Sykova E, Jendelova P. Migration, fate and in vivo imaging of adult stem cells in the CNS. Cell Death Differ. 2007; 14(7): 1336-42.
103. Theus MH, Wei L, Cui L, Francis K, Hu X, Keogh C, et al. In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Exp Neurol. 2008; 210(2): 656-70. doi: 10. 1016/j. expneurol. 2007. 12. 020.
104. Tung C-H. Fluorescent peptide probes for in vivo diagnostic imaging. Pept Sci. 2004; 76(5): 391-403. doi: 10. 1002/bip. 20139.
105. van Velthoven CTJ, Kavelaars A, van Bel F, Heijnen CJ. Regeneration of the ischemic brain by engineered stem cells: fuelling endogenous repair processes. Brain Res Rev. 2009; 61(1): 1-13. doi: 10. 1016/j. brainresrev. 2009. 03. 003.
106. Vande Velde G, Rangarajan JR, Toelen J, Dresselaers T, Ibrahimi A, Krylychkina O, et al. Evaluation of the specificity and sensitivity of ferritin as an MRI reporter gene in the mouse brain using lentiviral and adeno-associated viral vectors. Gene Therapy. 2011; 18: 594-605.
107. Veizovic T, Beech JS, Stroemer RP, Watson WP, Hodges H. Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells. Stroke. 2001; 32(4): 1012-9.
108. Vreys R, Soenen SJH, De Cuyper M, van der Linden A. Background migration of USPIO/MLs is a major drawback for in situ labeling of endogenous neural progenitor cells. Contrast Media Mol Imaging. 2011; 6: 1-6.
109. Vreys R, Velde GV, Krylychkina O, Vellema M, Verhoye M, Timmermans J-P, et al. MRI visualization of endogenous neural progenitor cell migration along the RMS in the adult mouse brain: validation of various MPIO labeling strategies. NeuroImage. 2010; 49(3): 2094-103.
110. Walczak P, Kedziorek DA, Gilad AA, Lin S, Bulte JWM. Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med. 2005; 54(4): 769-74. doi: 10. 1002/mrm. 20701.
111. Walczak P, Zhang J, Gilad AA, Kedziorek DA, Ruiz-Cabello J, Young RG, et al. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke. 2008; 39(5): 1569-74. doi: 10. 1161/strokeaha. 107. 502047.
112. Walker PA, Letourneau PA, Bedi S, Shah SK, Cox Jr CS. Progenitor cells as remote "bioreactors": neuroprotection via modulation of the systemic inflammatory response. World J Stem Cells. 2011; 3(2): 9-18.
113. Wang J, Tian M, Zhang H. PET molecular imaging in stem cell therapy for neurological diseases. Eur J Nucl Med Mol Imaging. 2011; 38: 1926-38. doi: 10. 1007/s00259-011-1860-7.
114. Weber R, Ramos-Cabrer P, Justicia C, Wiedermann D, Strecker C, Sprenger C, et al. Early prediction of functional recovery after experimental stroke: functional magnetic resonance imaging, electrophysiology, and behavioral testing in rats. J Neurosci. 2008; 28(5): 1022-9. doi: 10. 1523/jneurosci. 4147-07. 2008.
115. Weber R, Ramos-Cabrer P, Wiedermann D, van Camp N, Hoehn M. A fully noninvasive and robust experimental protocol for longitudinal fMRI studies in the rat. Neuroimage. 2006; 29(4): 1303-10. doi: 10. 1016/j. neuroimage. 2005. 08. 028.
116. Weber R, Wegener S, Ramos-Cabrer P, Wiedermann D, Hoehn M. MRI detection of macrophage activity after experimental stroke in rats: new indicators for late appearance of vascular degradation? Magn Reson Med. 2005; 54: 59-66.
117. Wei L, Cui L, Snider BJ, Rivkin M, Yu SS, Lee C-S et al. Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia. Neurobiology of Disease. 19(1-2): 183-93. 2005. doi: 10. 1016/j. nbd. 2004. 12. 016.
118. Wei L, Cui L, Snider BJ, Rivkin M, Yu SS, Lee C-S, et al. Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia. Neurobiol Dis. 2005; 19(1-2): 183-93. doi: 10. 1016/j. nbd. 2004. 12. 016.
119. Weigert R, Sramkova M, Parente L, Amornphimoltham P, Masedunskas A. Intravital microscopy: a novel tool to study cell biology in living animals. Histochem Cell Biol. 2010; 133(5): 481-91. doi: 10. 1007/s00418-010-0692-z.
120. Wu W, Chen X, Hu C, Li J, Yu Z, Cai W. Transplantation of neural stem cells expressing hypoxia-inducible factor-1[alpha] (HIF-1[alpha]) improves behavioral recovery in a rat stroke model. J Clin Neurosci. 2010; 17(1): 92-5. doi: 10. 1016/j. jocn. 2009. 03. 039.
121. Yazyev OV, Helm L. Gadolinium (III) ion in liquid water: Structure, dynamics, and magnetic interactions from first principles. J Chem Phys. 2007; 127(8): 084506-8.
122. Zhang ZG, Jiang Q, Zhang R, Zhang L, Wang L, Zhang L, et al. Magnetic resonance imaging and neurosphere therapy of stroke in rat. Ann Neurol. 2003; 53(2): 259-63. doi: 10. 1002/ana. 10467.
123. Zhao L-R, Duan W-M, Reyes M, Keene CD, Verfaillie CM, Low WC. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol. 2002; 174(1): 11-20. doi: 10. 1006/exnr. 2001. 7853.